Clinical Trial Update: TG4040 in Patients With Chronic HCV [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of TG4040 for chronic Hepatitis C has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TG4040

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C | Phase 1 | Status: WITHDRAWN